Hope for Brain Tumors: New Drug With Miami Roots Emerges
A new drug tested at Sylvester Comprehensive Cancer Center is generating encouraging results for patients with low-grade gliomas.
All Posts by
A new drug tested at Sylvester Comprehensive Cancer Center is generating encouraging results for patients with low-grade gliomas.
Mayo Clinic is bringing new hope for patients diagnosed with the most aggressive and treatment-resistant cancers.
A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data from the ADVANCE clinical trial.
The pioneering work at Sylvester is bringing hope to patients at a time when melanoma cases are on the rise.
After more than a decade of cancer treatment at UF Health, Dave felt supported every step of the way.
Two new studies seek to understand the disease more fully at the molecular level, with the ultimate aim of developing new treatments.
When an aggressive lymphoma threatened to derail a couple's happily ever after, the Mayo Clinic Comprehensive Cancer Center helped them find a future.
The community grants will support eight new and ongoing cancer screening and prevention projects this year.
The 2025 FACCA Annual Retreat, hosted by Moffitt Cancer Center, will be held Aug. 28-29 in Tampa.
Advances in treatment including surgical innovations are helping women and their health care teams personalize care and improve quality of life.